World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02968888
Date of registration: 10/11/2016
Prospective Registration: No
Primary sponsor: Norwegian School of Sport Sciences
Public title: Anabolic Effects of Whey and Casein After Strength Training in Young and Elderly
Scientific title: Effects of Whey and Casein Supplementation on Acute Anabolic Responses in Muscle After Strength Training in Young and Elderly
Date of first enrolment: August 2014
Target sample size: 43
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02968888
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Care Provider, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Norway
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Healthy in the sense that they can conduct training and testing

- Able to understand Norwegian language written and oral

- Between 18 and 45, or above 70 years of age

Exclusion Criteria:

- Diseases or injuries contraindicating participation

- Use of dietary supplements (e.g. proteins, vitamins and creatine)

- Lactose intolerance

- Allergy to milk

- Allergy towards local anesthetics (xylocain)



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Elderly
Healthy
Young
Intervention(s)
Other: Strength training
Dietary Supplement: Native whey
Dietary Supplement: Milk 1%
Dietary Supplement: Whey protein concentrate 80
Primary Outcome(s)
Mixed muscle fractional synthetic rate [Time Frame: One to five hours after a bout of strength training and protein consumption]
Mixed muscle fractional breakdown rate [Time Frame: From three to five hours after a bout of strength training and protein consumption]
Mixed muscle fractional synthetic rate [Time Frame: Three to one hours prior to a bout of strength training and protein consumption]
Mixed muscle fractional synthetic rate [Time Frame: From three to five hours after a bout of strength training and protein consumption]
Secondary Outcome(s)
Change in C-C motif chemokine 3 (CCL3) mRNA [Time Frame: 1 hour after training and protein intake]
Change in C-C motif chemokine 5 (CCL5) mRNA [Time Frame: 1 hour after training and protein intake]
Change in ABCA1 mRNA [Time Frame: 5 hous after training and protein intake]
Change in ABRA1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in CD36 mRNA [Time Frame: 5 hours after training and protein intake]
Change in cholesterol 25-hydroxylase (CH25H) mRNA [Time Frame: 1 hour after training and protein intake]
Change in ATP-binding cassette transporter (ABCA1) messenger ribonucleic acid (mRNA) [Time Frame: 1 hour after training and protein intake]
Change in IL10 mRNA [Time Frame: 5 hours after training and protein intake]
Change in IL8 mRNA [Time Frame: 5 hours after training and protein intake]
Change in C-C motif chemokine 2 (CCL2) mRNA [Time Frame: 1 hour after training and protein intake]
Change in E3 ubiquitin-protein ligase TRIM63 (TRIM63) mRNA [Time Frame: 1 hour after training and protein intake]
Change in interleukin-1 receptor antagonist protein (IL1RN) mRNA [Time Frame: 1 hour after training and protein intake]
Change in IGF1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in JUNB mRNA [Time Frame: 5 hours after training and protein intake]
Change in large neutral amino acids transporter small subunit 1 (SLC7A5) mRNA [Time Frame: 1 hour after training and protein intake]
Change in 4F2 cell-surface antigen heavy chain (SLC3A2) mRNA [Time Frame: 1 hour after training and protein intake]
Change in ACTA1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in KITLG mRNA [Time Frame: 5 hours after training and protein intake]
Change in myostatin (MSTN) mRNA [Time Frame: 1 hour after training and protein intake]
Change in matrix metalloproteinase-9 (MMP9) mRNA [Time Frame: 1 hour after training and protein intake]
Change in myosin-7 (MYH7) mRNA [Time Frame: 1 hour after training and protein intake]
Change in CCL2 mRNA [Time Frame: 5 hours after training and protein intake]
Change in forkhead box protein O1 (FOXO1) mRNA [Time Frame: 1 hour after training and protein intake]
Change in HGF mRNA [Time Frame: 5 hours after training and protein intake]
Change in IL1B mRNA [Time Frame: 5 hours after training and protein intake]
Change in C-X-C motif chemokine 16 (CXCL16) mRNA [Time Frame: 1 hour after training and protein intake]
Change in CXCL1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in IL6 mRNA [Time Frame: 5 hours after training and protein intake]
Change in interleukin-1B (IL1B) mRNA [Time Frame: 1 hour after training and protein intake]
Change in granulocyte colony-stimulating factor (CSF3) mRNA [Time Frame: 1 hour after training and protein intake]
Serum ureic acid [Time Frame: 180 and 60 min before, and 60, 10, 180 and 300 min after training and protein intake]
Change in FBXO32 mRNA [Time Frame: 5 hours after training and protein intake]
Change in hepatocyte growth factor (HGF) mRNA [Time Frame: 1 hour after training and protein intake]
Change in insulin-like growth factor I (IGF1) mRNA [Time Frame: 1 hour after training and protein intake]
Change in myosin-1 (MYH1) mRNA [Time Frame: 1 hour after training and protein intake]
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Change in PPARGC1A mRNA [Time Frame: 5 hours after training and protein intake]
Change in prostaglandin G/H synthase 2 (PTGS2) mRNA [Time Frame: 1 hour after training and protein intake]
Change in proton-coupled amino acid transporter 1 (SLC36A1) mRNA [Time Frame: 1 hour after training and protein intake]
Intracellular translocation of muscle RING-finger protein-1 (Murf-1) change from baseline [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Plasma insulin [Time Frame: 180 and 60 min before, and 45, 60, 75, 120, 160, 180, 200, 220 and 300 min after training and protein intake]
Serum urea [Time Frame: 180 and 60 min before, and 60, 10, 180 and 300 min after training and protein intake]
Change in CCL3 mRNA [Time Frame: 5 hours after training and protein intake]
Change in CCL5 mRNA [Time Frame: 5 hours after training and protein intake]
Change in growth-regulated alpha protein (CXCL1) mRNA [Time Frame: 1 hour after training and protein intake]
Change in IL17D mRNA [Time Frame: 5 hours after training and protein intake]
Change in interleukin-17D (IL17D) mRNA [Time Frame: 1 hour after training and protein intake]
Change in kit ligand (KITLG) mRNA [Time Frame: 1 hour after training and protein intake]
Change in MSTN mRNA [Time Frame: 5 hours after training and protein intake]
Change in MYH1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in MYH2 mRNA [Time Frame: 5 hours after training and protein intake]
Change in myosin-2 (MYH2) mRNA [Time Frame: 1 hour after training and protein intake]
Change in SLC7A5 mRNA [Time Frame: 5 hours after training and protein intake]
Change in TNF mRNA [Time Frame: 5 hours after training and protein intake]
Change in transcription factor jun-B (JUNB) mRNA [Time Frame: 1 hour after training and protein intake]
Plasma amino acid concentration [Time Frame: 180 and 60 min before, and 45, 60, 75, 120, 160, 180, 200, 220 and 300 min after training and protein intake]
Change in oxysterols receptor LXR-alpha (NR1H3) mRNA [Time Frame: 1 hour after training and protein intake]
Change in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) mRNA [Time Frame: 1 hour after training and protein intake]
Change in SLC36A1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in SLC3A2 mRNA [Time Frame: 5 hours after training and protein intake]
Change in alfa-actin (ACTA1) mRNA [Time Frame: 1 hour after training and protein intake]
Change in C-C motif chemokine 8 (CCL8) mRNA [Time Frame: 1 hour after training and protein intake]
Change in sodium-coupled neutral amino acid transporter 2 (SLC38A2) mRNA [Time Frame: 1 hour after training and protein intake]
Change in CCL8 mRNA [Time Frame: 5 hours after training and protein intake]
Change in CXCL16 mRNA [Time Frame: 5 hours after training and protein intake]
Muscle force generating capacity change from baseline [Time Frame: 15 min before, 15 and 300 min after, and 24 hours after training and protein intake]
Change in E3 ubiquitin-protein ligase TRIM63 (TRIM63) mRNA [Time Frame: 5 hours after training and protein intake]
Change in F-box only protein 32 (FBXO32) mRNA [Time Frame: 1 hour after training and protein intake]
Change in BRCA1-A complex subunit Abraxas (ABRA1) mRNA [Time Frame: 1 hour after training and protein intake]
Change in CH25H mRNA [Time Frame: 5 hours after training and protein intake]
Change in CSF3 mRNA [Time Frame: 5 hours after training and protein intake]
Change in forkhead box protein O3 (FOXO3A) mRNA [Time Frame: 1 hour after training and protein intake]
Change in FOXO1 mRNA [Time Frame: 5 hours after training and protein intake]
Change in IL1RN mRNA [Time Frame: 5 hours after training and protein intake]
Change in interleukin-10 (IL10) mRNA [Time Frame: 1 hour after training and protein intake]
Change in MMP9 mRNA [Time Frame: 5 hours after training and protein intake]
Change in NR1H3 mRNA [Time Frame: 5 hours after training and protein intake]
Change in nuclear receptor subfamily 4 group A member 3 (NR4A3) mRNA [Time Frame: 1 hour after training and protein intake]
Change in NR4A3 mRNA [Time Frame: 5 hours after training and protein intake]
Change in platelet glycoprotein 4 (CD36) mRNA [Time Frame: 1 hour after training and protein intake]
Change in FOXO3A mRNA [Time Frame: 5 hours after training and protein intake]
Change in interleukin-6 (IL6) mRNA [Time Frame: 1 hour after training and protein intake]
Plasma glucose [Time Frame: 180 and 60 min before, and 45, 60, 75, 120, 160, 180, 200, 220 and 300 min after training and protein intake]
Change in interleukin-8 (IL8) mRNA [Time Frame: 1 hour after training and protein intake]
Change in MYH7 mRNA [Time Frame: 5 hours after training and protein intake]
Change in PTGS2 mRNA [Time Frame: 5 hours after training and protein intake]
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Change in SLC38A2 mRNA [Time Frame: 5 hours after training and protein intake]
Intracellular translocation of forkhead box O3 (FOXO3a) change from baseline [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Change in TLR2 mRNA [Time Frame: 5 hours after training and protein intake]
Change in toll-like receptor 2 (TLR2) mRNA [Time Frame: 1 hour after training and protein intake]
Change in tumor necrosis factor (TNF) mRNA [Time Frame: 1 hour after training and protein intake]
Intracellular translocation of Atrogin1 change from baseline [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Ubiquitin [Time Frame: 30 min before, 1, 2.5 and 5 hours after training and protein intake]
Serum creatine kinase [Time Frame: 180 and 60 min before, and 60, 10, 180 and 300 min after training and protein intake]
Secondary ID(s)
Tine acute
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
The Research Council of Norway
Arkansas Children's Hospital Research Institute
Tine
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history